Invention Grant
- Patent Title: Method of treating myocardial infarction by administering a bi-specific fusion protein
-
Application No.: US14967980Application Date: 2015-12-14
-
Publication No.: US09718892B2Publication Date: 2017-08-01
- Inventor: Ulrik Nielsen , Thomas Wickham , Birgit Schoeberl , Brian Harms , Bryan Linggi , Matthew Onsum , Byron DeLaBarre , Shaun M. Lippow
- Applicant: Merrimack Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Merrimack Pharmaceuticals, Inc.
- Current Assignee: Merrimack Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Greenberg Traurig, LLP
- Agent Natalie Salem
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K16/44 ; A61K47/48 ; B82Y5/00 ; C07K14/475 ; C12N15/62 ; A61K45/06 ; C07K16/46 ; C07K14/47 ; C07K14/485 ; C07K14/65 ; A61K38/00
Abstract:
Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue. The bi-specific fusion proteins generally comprise: (a) a targeting polypeptide domain that binds to a target molecule; and (b) an activator domain that detectably modulates tissue regeneration.
Public/Granted literature
- US20160168269A1 Bi-Specific Fusion Proteins Public/Granted day:2016-06-16
Information query
IPC分类:
